References
- Thomas D. P. Pathogenesis of venous thrombosis. Haemostasis and Thrombosis, 3rd edition, A. L. Bloom, C. D. Forbes, D. P. Thomas, E. G.D. Tuddenham. Churchll-Livingstone, New York 1994; 1335–47
- Goldhaber S. Z. Epidemiology of pulmonary embolism and deep vein thrombosis. Haemostasis and Thrombosis, 3rd edition, A. L. Bloom, C. D. Forbes, D. P. Thomas, E. G.D. Tuddenham. Churchill-Livingstone, New York 1994; 1327–33
- Allaart C. F., Briët E. Familial venous thrombophlia. Haemostasis and Thrombosis, 3rd edition, A. L. Bloom, C. D. Forbes, D. P. Thomas, E. G.D. Tuddenham. Churchill-Livingstone, New York 1994; 1349–60
- Carter J. C. The natural history and epidemiology of venous thrombosis. Prog. Cardiovasc. Dis. 1994; 6: 423–38
- Dahlbäck B., Carlsson M., Svensson P. J. Familial thrombophlia due to a previously unrecognised mechanism characterized by a poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc. Natl. Acad. Sci. USA 1993; 90: 1004–8
- Koster T., Rosendaal F. R., de Ronde H., Briët E., Vandenbroucke J. P., Bertina R. M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503–6
- Rosendaal F. R., Koster T., Vandenbroucke J. P., Reitsma P. H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504–8
- Tait R. C., Walker I. D., Reitsma P. H., Islam S. I., McCall F., Poort S. R., Conkie J. A., Bertina R. M. Prevalence of protein C deficiency in the healthy population. Thromb. Haemost. 1995; 73: 87–93
- Tait R. C., Walker I. D., Perry D. J., Islam S. I., Daly M. E., McCall F., Coke J. A., Carrel R. W. Prevalence of antithrombin deficiency in the healthy population. Br. J. Haematol. 1994; 87: 106–12
- Bertina R. M., Koeleman R. P. C., Koster T., Rosendaal F. R., Dirven R. J., de Ronde H., Van der Velden P. A., Reitsma P. H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–7
- Vandenbroucke J. P., Koster T., Briët E., Reitsma P. H., Bertina R. M., Rosendaal F. R. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453–7